Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

PRME US Equity

Prime Medicine, Inc.Health Care · Biological Products, (No Diagnostic Substances) · CIK 1894562 · FY ends Dec 31
$3.54
+0.49 (+16.07%)
USD · as of 2026-08-19 · marketstack
9 8-K filings · 0 13D · 4 13G
DateEventWhat happened / filerSource
2026-08-068-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-07-088-K 8.01Other eventssec.gov ↗
2026-06-088-K 5.07Submission of matters to a vote of security holderssec.gov ↗
2026-05-078-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-04-168-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
2026-03-038-K 7.01Regulation FD disclosuresec.gov ↗
2026-03-038-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-02-1713G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by T. Rowe Price Investment Management, Inc.sec.gov ↗
2026-01-128-K 7.01Regulation FD disclosuresec.gov ↗
2025-11-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by T. Rowe Price Investment Management, Inc.sec.gov ↗
2025-11-1213G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by GV 2019, L.P.sec.gov ↗
2025-11-078-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2025-11-0513G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by FMR LLCsec.gov ↗
2025-09-088-K 7.01Regulation FD disclosuresec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2025-09-08

Every row is a filed document, checked against its EDGAR index.